Trial intelligence / Profile preview

Intrathecal Morphine in Robotic Coronary Revascularization

NCT03241485Phase 4Completed

Sponsor
University of Chicago
Start
Jun 2018
Primary completion
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing Placebo with Intrathecal morphine (2 arms). Primary endpoint: Postoperative Morphine Consumption at 24 hours. Started Jun 2018; status: completed.

02

Drugs

morphine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03241485.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03241485.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call